New TissueCypher® Validation Study identifies high risk Barrett's Esophagus patients who are 46x more likely to have cancer at time of biopsy

Study indicates that TissueCypher® may detect a field effect associated with high grade dysplasia and cancer, which can be challenging to recognize with standard endoscopic and histologic surveillance
http://www.prnewswire.com/news-releases/new-tissuecypher-validation-study-identifies-high-risk-barretts-esophagus-patients-who-are-46x-more-likely-to-have-cancer-at-time-of-biopsy-300342677.html